NEW YORK, Sept. 10, 2018 /PRNewswire/ -- Report Scope:The protein analysis market has significant potential bolstered by the rising demand from drug discovery and personalized medicine.The capabilities and possibilities of protein analysis market growth increase with growing new technologies and technological advancement in the market.Read the full report: https://www.reportlinker.com/p05501536
Emerging economies such as China, Japan and South Korea are considered to be lucrative regions that are creating ample opportunities and scope for the protein analysis market.This market is expected to obtain investments and funding from government and private ventures, research institutes and universities to explore its potential.Growing clinical trials, drug discovery and clinical diagnostic and research through the protein analysis market will further boost this market in the near future.Sedentary lifestyles, unhealthy eating habits and upsurge in infectious viral and bacterial diseases are also creating opportunities for the protein analysis market.The global rise in infectious and noninfectious diseases, growing population, technological advancements and innovation are some other factors creating considerable demand within the protein analysis market.The scope of this study covers the current market for drug discovery, clinical diagnostic and research into personalized medicine and so forth.The report also includes regulatory aspects, current and developing technologies, market projections and market share.Patents, clinical trials, innovations and opportunities, as well as the latest trends are also analyzed and discussed.The report intends to explain the key trends of protein analysis technologies.It also discusses the market determinants that act as motivating and restraining factors and provides insights to stakeholders and potential entrants. The report will be a key decision-making tool for government organizations, researchers, private players, angel investors, potential entrants and so forth.Report Includes:- 56 data tables and 37 additional tables- An overview of the global market for protein analysis and oncoproteomics within the biotechnology industry- Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023- Coverage of the current market for drug discovery, clinical diagnostic and research into personalized medicine and so forth- Discussion of factors such as global rise in infectious and noninfectious diseases, growing population, technological advancements and innovation, which create considerable demand within the protein analysis market- Relevant patents analysis, clinical trials, innovations and opportunities- Evaluation of key trends, present and future market strategies, technological advancements, and regulatory updates that have a major say in the protein analysis market- Company profiles of the leading industry players, including Bio-Rad Laboratories Inc., Danaher Corp., GE Healthcare, GlaxoSmithKline PLC, GD Biosciences and PfizerSummaryThe global protein analysis market has been achieving significant growth rate and the market is expected to grow with a compound annual growth rate (CAGR) REDACTED during the forecasted period of 2018 through 2023.The market size in 2017 was REDACTED, and this is estimated to exceed REDACTED by 2023.Protein analysis is a term used for analysis of the entire protein complement of a cell oran organism under given set of conditions.It has been used widely in various applications such as drug discovery and clinical diagnostics.Rising demand and U.S. Food and Drug Administration (FDA) approvals of personalized medicines due to their numerous benefits have been two of the major factors driving themarket growth. The proportion of FDA approval of personalized drugs increased from REDACTED in 2005 to REDACTED in 2016. As protein analysis is widely used for personalized medicines, it enables the market to grow significantly. Additionally, a rising aging population and an increase in lifestyle diseases has been motivating the market. According to theWorld Health Organization, cardiovascular diseases (CVDs) have been estimated as one of the major causes of mortality, and they account for more than 17.3 million deaths per year. It is further estimated that the fatalities due to CVDs are expected to reach 23.6 million by 2030.These lifestyle diseases are growing at a significant rate, and protein analysis can be act as a bridge for drug discovery, customized medicines, biomarkers and research programs.Further, the diabetic population was recorded as 415 million in 2015, and it is projected that this will reach 642 million by 2040.This prevalence of lifestyle-related disorders reflects the need for protein analysis as a bridge for the drug discovery, customized medicines and biomarkers, thus promoting the market.Healthcare research and development (R&D) spending plays a significant role in the growth of the protein analysis market.As transformative research is responsible for development of new biomarkers and nextgeneration diagnostics and therapeutics, healthcare expenditure is a crucial element for the market.Healthcare spending per capita in the U.S. was recorded as REDACTED in 2016, while healthcare spending per person in Switzerland was REDACTED, followed by Germany with REDACTED and the Netherlands with REDACTED.Globally, national governments have been revising their healthcare expenditure taking into account increasing R&D.As a result, overall increase in the healthcare expenditure globally would drive the market, as research institutes will be able to obtain increased funding by governments for drug discovery.Strict regulatory approvals of protein analysis instruments have been one of the major restraints of the protein analysis market. These products require regulatory approval by the FDA and other regulatory bodies as they govern a broad range of activities such as quality management, design and development, labeling, manufacturing and so forth. Additionally, there are various regulations formanufacturers and their customers, along with regulations in the areas of health and safety, packaging, product content and trade restrictions.Manufacturers are required to follow complex foreign and U.S. laws and regulations, such as the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and other local laws, violations of which can result in penalties and restrictions on the conduct of business. Additionally, high costs of these instruments affect their adoption in the industry. For instance, the Xevo TQ MS with Acquity HPLC (UHPLC) system offered by Waters Corp. costs around REDACTED, while Applied Biosystems' Sciex API 4000 LC-MS/MS system is available at a cost of around REDACTED. Both of these factors have a negative effect on the growth of protein analysis market. However, technological advancements in mass spectrometry/liquid chromatography (MS/LC) instrumentation, protein separation and emerging markets in developing economies such as China, Japan and South Korea are expected to drive the market growth in the upcoming years.Read the full report: https://www.reportlinker.com/p05501536
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected]
US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
View original content:http://www.prnewswire.com/news-releases/protein-analysis-subfocus-on-oncoproteomics-300709589.html
SOURCE Reportlinker
